Atlas Trials

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome

Clinical trial NCT06118255 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06118255
Sponsor
UCB BIOSCIENCES, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Dravet Syndrome
Start date
2024-05-21
Primary completion
2026-09-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.